Micropathology
Private Company
Funding information not available
Overview
Micropathology Ltd is an established, revenue-generating private diagnostics service provider operating from Coventry, UK. The company has built a robust, accredited laboratory offering a comprehensive portfolio of tests, including Sanger/Next-Generation Sequencing, pathogen detection, and serology, primarily for the clinical and research markets. Its business model is centered on providing specialized, clinically supported diagnostic services and contract research, with a strong emphasis on quality, integration (HL7/LIMS), and client collaboration. While not developing its own therapeutic pipeline, it acts as a critical enabler for disease management and biomedical research.
Technology Platform
Integrated diagnostic laboratory utilizing Sanger sequencing, Next-Generation Sequencing (NGS), molecular pathogen detection (e.g., PCR), and antibody/antigen detection (serology). Supported by in-house assay development, HL7/LIMS digital integration, and a secure results portal.
Opportunities
Risk Factors
Competitive Landscape
Competes with other specialist referral labs, larger commercial diagnostic service providers (e.g., The Doctors Laboratory, Viapath), and in-house NHS hospital laboratories. Differentiation is achieved through niche expertise in rapid pathogen detection, genetic diagnostics, personalized client service, and a strong focus on digital integration and clinical support.